Jim Silverman

Jim Silverman is the managing member of RRC Bio Fund LP, a Boston-based hedge fund focused on small-cap biotech. RRC Bio was launched in 2007. Silverman also founded Risk/Reward Capital Management in 1997, a registered investment advisory. He lives in Cambridge, Mass., and received a BBA in finance from The George Washington University.

Recent Articles By The Author

Ariad Pharma: The Contrarian Long Thesis

Ariad Pharma: The Contrarian Long Thesis

Iclusig may find use in other cancers and '113 is better than the market believes.

Cell Therapeutics: Addicted to Reverse Stock Splits

Cell Therapeutics: Addicted to Reverse Stock Splits

Through four reverse stock splits, Cell Therapeutics has lost 99% of its value.

Programmed Insider Buying? Yes, at Insmed and United Therapeutics

Programmed Insider Buying? Yes, at Insmed and United Therapeutics

Instead of selling stock whenever the wind blows, biotech execs should be buying.

He's Baaaaack . . .

He's Baaaaack . . .

With President Obama re-elected it's back to discussing changes to the tax code and the effect on dividends.

Genta: 1998-2012

Genta: 1998-2012

The strange but true tale of a beleaguered, bankrupt biotech firm with 100 quadrillion shares outstanding.